Top compounds associated with response to TRPC7


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA BHG712 GDSC1000 pan-cancer AAC 0.036 0.2
mRNA TAE684 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.072 0.2
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.039 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.2
mRNA Cyclopamine FIMM pan-cancer AAC -0.19 0.2
mRNA BMS-270394 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA tigecycline CTRPv2 pan-cancer AAC -0.065 0.2
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.046 0.2
Download CSV